Back to search

Article

Defining Type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis

2020-07-21

Abstract excerpt

<title>Abstract</title> <p><bold>Background </bold>Asthma is a chronic disease characterized by airway hyperresponsiveness, inflammation and mucus production. In Type 2 asthma, two phenotypic components are often co-expressed (eosinophilic and allergic). Elevated biomarker levels, such as eosinophils (EOS), fraction of exhaled nitric oxide (FeNO) and immunoglobulin E (IgE), are key clinical indicators of Type 2 i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6b824415-b5af-5501-9ffd-86b010508991
DOI
10.21203/rs.3.rs-44856/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Defining Type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysisDOI 10.21203/rs.3.rs-44856/v1
Select a neighboring publication to make it the new centre.